Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization.

Jonathan CorrenDavid J JacksonThomas B CasaleLarry BorishKlaus Friedrich Rabe William Walter BusseJorge F MasperoDaniel J JacksonNadia DaizadehArman AltincatalAmr RadwanAngela KhodzhayevMichel DjandjiJuby A Jacob-NaraPaul J RoweYamo Deniz

Published in: Journal of asthma and allergy (2023)

ClinicalTrials.gov Identifier: NCT02414854.

Keyphrases

atopic dermatitis
chronic obstructive pulmonary disease
lung function
high intensity
early onset
allergic rhinitis
drug induced
cystic fibrosis